Samuel Acuff
Samuel Acuff
Dr. Joseph Schacht - Can We Leverage GLP-1s for Substance Use Disorder?
Dr. Joseph Schacht - Can We Leverage GLP-1s for Substance Use Disorder?
Dr. Joseph Schacht - Can We Leverage GLP-1s for Substance Use Disorder?
Wednesday 11th March 2026
Explore GLP-1 medications' potential in treating substance use disorders with Dr. Joseph Schacht and hosts Dr. Noah Emery and Samuel Acuff.
66 minutes
Hopeful
Informative
Inspiring
Educational
Encouraging
About this podcast
Author:
Samuel Acuff
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Navigating Alcohol Dependency
Navigating Intimate Relationships
Body & Mind
Links:
Visit site
Episodes:
71 (View all)
Do you want to link to this podcast?
Get the buttons here!Could GLP-1s Revolutionise Substance Use Disorder Treatment?
Episode Overview
- GLP-1 medications show promise in reducing alcohol cravings.
- Current trials indicate potential effectiveness but require more data.
- Accessibility and cost are significant challenges for widespread use.
- Ethical considerations include ensuring equitable access to treatments.
- Combination with behavioural therapies may enhance long-term outcomes.
"This is the most hopeful that I can remember feeling about the prospect for a medication to actually be effective."
Curious about how innovative treatments could change the landscape of addiction recovery? In this engaging episode, Dr. Joseph Schacht joins hosts Dr. Noah Emery and Samuel Acuff to discuss the potential of GLP-1 medications as a treatment for substance use disorders. Known for their success in weight loss and diabetes management, GLP-1s are now being explored for their unexpected effects on alcohol consumption. Dr.
Schacht, an Associate Professor at the University of Colorado Anschutz, shares his extensive research and insights into how these medications might help reduce cravings and drinking behavior. Listeners will gain a deeper understanding of the science behind GLP-1s, including their mechanisms and the promising, albeit early, clinical trial results. The conversation also touches on the challenges and ethical considerations surrounding the accessibility and long-term use of these medications, especially for underserved populations. Dr.
Schacht offers a balanced view, highlighting both the excitement around potential new treatments and the need for cautious optimism until more data is available. This episode is not just for those in recovery or practitioners but also for policymakers who need to consider equitable access to emerging treatments. Dr. Schacht's thoughtful approach provides hope for more effective solutions in the near future, making this a must-listen for anyone interested in the evolving field of addiction treatment.
Could GLP-1s be the game-changer we've been waiting for in addiction recovery?